Loading company…
Shanghai-based biotechnology company offering genomic and proteomic sequencing services for research and healthcare clients.
Founded in 2011 and based in Shanghai, China, Shanghai Personal Biotechnology Co., Ltd. offers genomic and proteomic sequencing services using platforms including Illumina NovaSeq and PacBio. Its offerings include single-cell sequencing, microbiome analysis and bioinformatics for academic institutions, healthcare providers and pharmaceutical companies. In 2017 it reported revenue of USD 7,393,396.60. In June 2018 the company raised a Series A of USD 3.10 mn led by Yangtze River Investment Fund Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in